DYN
Price
$9.95
Change
+$0.71 (+7.68%)
Updated
Jul 25 closing price
Capitalization
1.41B
3 days until earnings call
SYRE
Price
$17.79
Change
+$0.19 (+1.08%)
Updated
Jul 25 closing price
Capitalization
1.07B
3 days until earnings call
Interact to see
Advertisement

DYN vs SYRE

Header iconDYN vs SYRE Comparison
Open Charts DYN vs SYREBanner chart's image
Dyne Therapeutics
Price$9.95
Change+$0.71 (+7.68%)
Volume$3.09M
Capitalization1.41B
Spyre Therapeutics
Price$17.79
Change+$0.19 (+1.08%)
Volume$841.4K
Capitalization1.07B
DYN vs SYRE Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. SYRE commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (DYN: $9.95 vs. SYRE: $17.79)
Brand notoriety: DYN and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 111% vs. SYRE: 149%
Market capitalization -- DYN: $1.41B vs. SYRE: $1.07B
DYN [@Biotechnology] is valued at $1.41B. SYRE’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • SYRE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +10.31% price change this week, while SYRE (@Biotechnology) price change was +9.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.41B) has a higher market cap than SYRE($1.07B). SYRE YTD gains are higher at: -23.582 vs. DYN (-57.767). SYRE has higher annual earnings (EBITDA): -214.36M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. SYRE (565M). SYRE has less debt than DYN: SYRE (0) vs DYN (23.3M). DYN (0) and SYRE (0) have equivalent revenues.
DYNSYREDYN / SYRE
Capitalization1.41B1.07B131%
EBITDA-395.31M-214.36M184%
Gain YTD-57.767-23.582245%
P/E RatioN/A1.68-
Revenue00-
Total Cash677M565M120%
Total Debt23.3M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNSYRE
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLCGX32.710.20
+0.62%
Saratoga Large Capitalization Growth I
IVPSX12.860.07
+0.55%
Voya Small Company Port S
FASMX21.910.02
+0.09%
Fidelity Asset Manager 50%
PWITX20.18-0.08
-0.39%
PACE International Equity Invmt P2
MLPTX9.64-0.05
-0.52%
Invesco SteelPath MLP Select 40 Y

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+7.68%
RNA - DYN
57%
Loosely correlated
+9.21%
SYRE - DYN
54%
Loosely correlated
+1.08%
CRNX - DYN
54%
Loosely correlated
+1.91%
XNCR - DYN
54%
Loosely correlated
N/A
IDYA - DYN
52%
Loosely correlated
-1.33%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+1.08%
IDYA - SYRE
60%
Loosely correlated
-1.33%
BEAM - SYRE
58%
Loosely correlated
+3.68%
CGON - SYRE
57%
Loosely correlated
-0.15%
XNCR - SYRE
57%
Loosely correlated
N/A
KRYS - SYRE
54%
Loosely correlated
-1.59%
More